Ropivacaine
A long-acting amide-type local anesthetic used for regional anesthesia and analgesia, including epidural, peripheral nerve, and local infiltration anesthesia. It acts primarily by reversibly blocking voltage-gated sodium channels in nerve fibers, thereby inhibiting the generation and propagation of action potentials. Ropivacaine is the pure S-enantiomer and has lower cardiotoxic and central nervous system toxicity than bupivacaine
CAS Number: 84057-95-4
Molecular Mass: 274.4 g/mol
Formula: C17H26N2O
Smiles: CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
Synonymes:
Ropivacaine, 84057-95-4, (S)-Ropivacaine, Ropivacaina, Ropivacainum, (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide, Ropivicaine, 7IO5LYA57N, TLC590, (-)-1-Propyl-2',6'-pipecoloxylidide, TLC-590, L-N-n-propylpipecolic acid-2,6-xylidide, CHEBI:8890, (S)-(-)-1-propyl-2',6'-pipecoloxylidide, DTXSID4040187, 1-propyl-2',6'-pipecoloxylidide, AL-381, (-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilid, LEA-103, CHEBI:60802, RefChem:55986, LEA103, DTXCID2020187, N01BB09, 1 Propyl 2',6' pipecoloxylidide, AL381, 617-525-1, 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, Ropivacaine [INN], (S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide, Ropivacaina [Spanish], Ropivacaine base, MFCD00864425, Ropivacainum [INN-Latin], Ropivacaina [INN-Spanish], (2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide, S-Ropivacaine, Ropivacaine (INN), Noropine, Narop, Naropin (TN), NCGC00164597-01, Ropivacaine [INN:BAN], UNII-7IO5LYA57N, LEA 103, 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-, Ropivacaine (Standard), (2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide, ROPIVACAINE [MI], ROPIVACAINE [VANDF], SCHEMBL33292, ROPIVACAINE [USP-RS], ROPIVACAINE [WHO-DD], BIDD:GT0203, Narop, Noropine, LEA-103, GTPL7602, orb1310661, orb3025113, CHEMBL1077896, HY-B0563R, ZKMNUMMKYBVTFN-HNNXBMFYSA-N, ALBB-038629, HY-B0563, MSK10272, BBL102321, EBC-03920, s5504, STL556120, T0386L, AKOS017343283, CCG-267197, DB00296, AS-35173, DA-48865, FR178417, SY102338, CS-0009514, NS00001426, R0251, C07532, D08490, AB00698466-07, AB00698466_10, EN300-7436767, Q279504, (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDINE, BRD-K50938786-003-11-8, (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide, Z2235811359, (s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide, (S)-(-)-1-PROPYLPIPERIDINE-2-CARBOXYLIC ACID (2,6-DIMETHYLPHENYL)AMIDE
Bioactivity: Local anesthetic; voltage-gated sodium channel blocker
Solubility in Different Solvents
| Solvent | Temperature [K] | Crystal form | Solubility [mg/mL] | Reference |
|---|---|---|---|---|
| Acetone | 278.15 | - | 25.1 | [487] |
| Acetone | 283.15 | - | 30.31 | [487] |
| Acetone | 288.15 | - | 37.23 | [487] |
| Acetone | 293.15 | - | 45.45 | [487] |
| Acetone | 298.15 | - | 55.74 | [487] |
| Acetone | 303.15 | - | 68.87 | [487] |
| Acetone | 308.15 | - | 86.18 | [487] |
| Acetone | 313.15 | - | 99.2 | [487] |
| Acetone | 318.15 | - | 128.0 | [487] |
Molecule 3D descriptors
| Descriptor | Value |
|---|---|
| PMI1 | 1039.1448 |
| PMI2 | 2408.3094 |
| PMI3 | 2663.5386 |
| NPR1 | 0.3901 |
| NPR2 | 0.9042 |
| RadiusOfGyration | 3.3369 |
| InertialShapeFactor | 0.0009 |
| Eccentricity | 0.9208 |
| Asphericity | 0.2452 |
| SpherocityIndex | 0.4925 |
| PBF | 1.2351 |